Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.
Khan SA, Chatterton RT, Michel N, Bryk M, Lee O, Ivancic D, Heinz R, Zalles CM, Helenowski IB, Jovanovic BD, Franke AA, Bosland MC, Wang J, Hansen NM, Bethke KP, Dew A, Coomes M, Bergan RC.
Khan SA, et al. Among authors: hansen nm.
Cancer Prev Res (Phila). 2012 Feb;5(2):309-19. doi: 10.1158/1940-6207.CAPR-11-0251.
Cancer Prev Res (Phila). 2012.
PMID: 22307566
Free PMC article.
Clinical Trial.